Platelet-Rich Plasma Injections
Customize your policy alerts
Sign up for wellfleet Policy GL-019 alerts
Get alerted when Policy GL-019 changes without checking for updates manually.
Monitor payer policy activity
This payment guideline describes how Wellfleet evaluates platelet-rich plasma utilization before payment for applicable commercial and student health plans, including criteria for nursing review, physician review, and experimental or investigational determinations.
No material clinical or coverage changes in this revision.
Coverage Criteria
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.